Prince of Songkla University is the first university in southern Thailand, established in 1967. The name of the university was granted by the King Bhumibol Adulyadej in honor of Prince Mahidol Adulyadej, Prince of Songkla, the King's father. The university consists of four campuses and one education service area.

During the past decade, Prince of Songkla University conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prince of Songkla University" #1 sponsor was "Prince of Songkla University" with 15 trials, followed by "Sutep Jaruratanasirikul" with 3 trials sponsored, "Janssen Sciences Ireland UC" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prince of Songkla University" #1 collaborator was "Prince of Songkla University" with 3 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Hospital Israelita Albert Einstein" with 1 trials as a collaborator, "Mahidol Oxford Tropical Medicine Research Unit" with 1 trials as a collaborator and "The Royal Golden Jubilee PhD funding of Thailand" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Prince of Songkla University" are "Ventilator-Associated Pneumonia" (2 trials), "Acute Respiratory Failure" (1 trials), "Anesthesia Competences (Self-evaluation)" (1 trials), "Anterior Cruciate Ligament Injury" (1 trials) and "Carpal Tunnel Syndrome" (1 trials). Many other conditions were trialed in "Prince of Songkla University" in a lesser frequency.

Most popular intervention types in "Prince of Songkla University" are "Drug" (12 trials), "Device" (4 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "JNJ-56136379" (2 trials), "5-Fluorouracil" (1 trials), "Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device." (1 trials), "Atezolizumab" (1 trials) and "Baby talcum" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prince of Songkla University" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Prince of Songkla University". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Prince of Songkla University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Prince of Songkla University, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".